Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSTK1 | Q9Y2Q3 | 2/20 | 0.50 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.47 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.47 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.47 |
| ▸ | BLM | P54132 | 1/20 | 0.47 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.46 |
| ▸ | ENPEP | Q07075 | 3/20 | 0.44 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.42 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.42 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6422160 | 0.96 | ABCC4 (0.54) | GSTK1ABCC4MAPTLMNATSHR | |
| SCHEMBL21628120 | 0.96 | ABCC4 (0.54) | GSTK1ABCC4MAPTLMNATSHR | |
| SCHEMBL2935706 | 0.96 | ABCC4 (0.54) | GSTK1ABCC4MAPTLMNATSHR | |
| SCHEMBL7705158 | 0.91 | TSHR (0.52) | GSTK1ABCC4MAPTLMNATSHR | |
| SCHEMBL27906416 | 0.88 | HDAC3 (0.46) | GSTK1ABCC4MAPTLMNATSHR | |
| SCHEMBL10438731 | 0.87 | ALDH1A1 (0.56) | MAPTLMNATSHRBLMMEN1 | |
| SCHEMBL28562412 | 0.87 | FFAR4 (0.62) | MAPTLMNATSHRBLMMEN1 | |
| SCHEMBL1733703 | 0.86 | ALDH1A1 (0.46) | TSHRNFKB1SLC6A2SLC6A4BLM | |
| SCHEMBL27592646 | 0.84 | FFAR4 (0.50) | ABCC4MAPTLMNATSHRNFKB1 | |
| SCHEMBL5617526 | 0.84 | FFAR4 (0.50) | ABCC4MAPTLMNATSHRNFKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6348623-B2 | (CO)POLYMERS OF 1-ACETOXY-2-METHOXY-3-BUTENE FOR EXAMPLE; CAN COPOLYMERIZE WITH VINYL ACETATE; REACTING ACETOACETOXY FUNCTIONAL POLYMER WITH AMMONIA OR PRIMARY OR SECONDARY AMINES TO FORM ENAMINE FUNCTIONAL POLYMERS; COATINGS | EASTMAN CHEMICAL COMPANY | 2002-02-19 | — | — | US | disclosed |
| US-20010051690-A1 | Polymers of 3-butene esters, their preparation and use | EASTMAN CHEMICAL COMPANY | 2001-12-13 | — | — | US | disclosed |
| CN-1276800-A | Polymers of 3-butenoic esters, process for their preparation and their use | EASTMAN CHEMIAL CO (US) | 2000-12-13 | — | — | CN | disclosed |
| US-6160057-A | Polymers of 3-butene esters, their preparation and use | EASTMAN CHEMICAL COMPANY (US) | 2000-12-12 | — | — | US | disclosed |
| US-6121400-A | FREE-RADICAL POLYMERIZATION PRODUCT; FOR COATING COMPOSITIONS SUCH AS INKS, ADHESIVES, PAINTS, AND FILMS | EASTMAN CHEMICAL COMPANY (US) | 2000-09-19 | — | — | US | disclosed |
| US-6121399-A | Polymers of 3-butene esters, their preparation and use | EASTMAN CHEMICAL COMPANY (US) | 2000-09-19 | — | — | US | disclosed |
| EP-1023340-A1 | POLYMERS OF 3-BUTENE ESTERS, THEIR PREPARATION AND USE | EASTMAN CHEMICAL COMPANY (US) | 2000-08-02 | — | — | EP | disclosed |
| WO-1999020666-A1 | POLYMERS OF 3-BUTENE ESTERS, THEIR PREPARATION AND USE | EASTMAN CHEMICAL COMPANY (US) | 1999-04-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010051690-A1 | Polymers of 3-butene esters, their preparation and use | CCNT1, C1S, H1-3 | GSTK1 3154/4885ABCC4 2049/4885MAPT 868/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.